Market Overview

Athenahealth Notches Price Target Increase After CEO Departure, Strategic Alternative Announcement

Athenahealth Notches Price Target Increase After CEO Departure, Strategic Alternative Announcement
Related ATHN
10 Biggest Price Target Changes For Tuesday
Earnings Scheduled For July 30, 2018
Prosight Management, LP Buys Cigna Corp, athenahealth Inc, Kura Oncology Inc, Sells Shire PLC, ... (GuruFocus)

The Street reacted to athenahealth, Inc (NASDAQ: ATHN) CEO Jonathan Bush's resignation and the company's pursuit of strategic alternatives with unmistakable enthusiasm. The 8.5-percent stock pop resonated strongly with one of the company’s most bullish analysts.

The Rating

Piper Jaffray analyst Sean Wieland maintained an Overweight rating on athenahealth and raised the price target from $155 to $179.

The Thesis

Piper Jaffray considered athenahealth one of the best assets in its sector prior to Wednesday's announcement. 

“The company's presence at the point of care and ability to crowdsource best practices in clinical and financial workflow are unsurpassed, in our view,” Wieland said in a midday note. 

The health care services company enters its new phase, then, in strong industry standing.

Wieland said he expects “no shortage of bidders” given athenahealth’s recurring revenue and ability to drive margins. Likely prospective buyers apart from Elliott Management include software companies like Microsoft Corporation (NASDAQ: MSFT), Oracle Corporation (NYSE: ORCL) and, inc. (NYSE: CRM), the analyst said. 

Price Action

Athenahealth shares were up 4.26 percent at $157.58 at the time of publication Wednesday afternoon. 

Related Links:

Analyst: When Americans Sneeze, Teladoc And Athenahealth Profit

Elliott Pushes Athenahealth To Commence A Sale Process: 'Shareholders Have Spoken'

Latest Ratings for ATHN

Jul 2018Canaccord GenuityMaintainsHoldHold
Jul 2018Stifel NicolausMaintainsHoldHold
Jun 2018OppenheimerMaintainsOutperformOutperform

View More Analyst Ratings for ATHN
View the Latest Analyst Ratings

Posted-In: Analyst Color News Health Care Price Target Reiteration Management M&A Top Stories Best of Benzinga


Related Articles (ATHN + CRM)

View Comments and Join the Discussion!

Fuelcell Energy Q2 Earnings Preview

Analyst Turns Bullish On Floor & Décor, Projects Comp, EPS Growth Ahead